EP2429284B1 - A method and composition for the control of ectoparasites - Google Patents
A method and composition for the control of ectoparasites Download PDFInfo
- Publication number
- EP2429284B1 EP2429284B1 EP10718271.9A EP10718271A EP2429284B1 EP 2429284 B1 EP2429284 B1 EP 2429284B1 EP 10718271 A EP10718271 A EP 10718271A EP 2429284 B1 EP2429284 B1 EP 2429284B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- viscosity
- use according
- volume
- centistokes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 141
- 244000078703 ectoparasite Species 0.000 title claims description 10
- 238000000034 method Methods 0.000 title description 7
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 38
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 38
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 25
- 229960001275 dimeticone Drugs 0.000 claims description 23
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 238000011282 treatment Methods 0.000 claims description 15
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims description 10
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims description 10
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 8
- 230000009974 thixotropic effect Effects 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 235000012239 silicon dioxide Nutrition 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 5
- 150000003505 terpenes Chemical class 0.000 claims description 5
- 206010061217 Infestation Diseases 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000011321 prophylaxis Methods 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- 235000007586 terpenes Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 description 38
- 238000012360 testing method Methods 0.000 description 34
- 241001674048 Phthiraptera Species 0.000 description 29
- -1 aryl siloxane Chemical class 0.000 description 29
- 239000007788 liquid Substances 0.000 description 22
- 235000013601 eggs Nutrition 0.000 description 20
- 210000004681 ovum Anatomy 0.000 description 18
- 208000028454 lice infestation Diseases 0.000 description 14
- 241000517307 Pediculus humanus Species 0.000 description 13
- 239000007921 spray Substances 0.000 description 11
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 8
- 230000001984 ectoparasiticidal effect Effects 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 210000003278 egg shell Anatomy 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241000517308 Pediculus humanus capitis Species 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 230000002969 morbid Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 238000003359 percent control normalization Methods 0.000 description 4
- 230000007480 spreading Effects 0.000 description 4
- 238000003892 spreading Methods 0.000 description 4
- 238000009834 vaporization Methods 0.000 description 4
- 230000008016 vaporization Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 238000010884 ion-beam technique Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 241000118205 Ovicides Species 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000004125 X-ray microanalysis Methods 0.000 description 1
- 238000000441 X-ray spectroscopy Methods 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003038 pediculicidal effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
Definitions
- the present invention relates to ectoparasiticidal compositions for use in the treatment or prophylaxis of a human or animal of an infestation by ectoparasites, in particular head lice and their ova.
- compositions for the control of ectoparasites have traditionally comprised conventional insecticides.
- many of these substances have an unpleasant odour and may cause allergic reactions.
- More recently non-toxic products have been found that are clinically effective.
- some silicone polymers which are widely used in personal care products such as in shampoo and hair conditioners, have been found to be highly effective in eradicating both head lice and their ova when used in certain formulations.
- US4146619 describes the use of linear alkyl or aryl siloxane polymers having a viscosity of less than about 20,000 centistokes for use as a pediculicide and/or ovicide. Such polymers are safe to use. However, it has subsequently been found that compositions comprising siloxane polymers with viscosities in excess of 20,000 centistokes are more clinically effective.
- US6683065 describes a composition for use as a pediculicide consisting of at least about 40% of polydimethylsiloxane wherein the surface tension of the composition is below about 25 dynes/centimeter at 20° C and the viscosity of the composition is above about 200 centistokes at 20° C.
- This composition uses the efficacy of dimeticones, but the high viscosity specified does not allow penetration of the composition through and across the surfaces of the hair.
- such high viscosity siloxanes have been found difficult wash out of the hair satisfactorily after use. This makes them difficult and unpleasant to use.
- WO 01/19190 describes the use of a composition comprising as active ingredient at least one siloxane derivative, other than solely a linear alkyl or aryl siloxane having a viscosity less than 20,000 centistokes, for the control of ectoparasites and, in particular, pediculous infestations.
- this patent describes the use of compositions for the control of head lice that comprise a mixture of a volatile siloxane, such as a cyclomethicone, and a non-volatile siloxane, such a dimeticone.
- the volatile siloxane acts to spread the non-volatile siloxane over the scalp and hair and then evaporates leaving the non-volatile siloxane as an active deposit coating the hair and any lice and ova that are present.
- One disadvantage of this product is that it has a limited efficacy against head lice ova.
- the major disadvantage of this composition and of other ectoparasiticidal compositions containing volatile siloxanes, such as cyclomethicone is that they are flammable or combustible and therefore a fire risk.
- viscosity can be expressed as absolute viscosity, which is measured in poises or centipoises, or as kinematic viscosity.
- Kinematic viscosity is the ratio of absolute viscosity to density and is measured in stokes or centistokes. For convenience herein viscosity will be expressed in centistokes unless otherwise stated. Where the density of a substance is close to 1, which is the case with dimethicones that typically have specific gravities between 0.96 and 0.98, absolute and kinematic viscosity have almost the same numerical value.
- WO 2007104345 also describes a composition for combating ectoparasites, in particular head lice and their ova, the aim of which is to avoid the use of cyclic siloxanes that it considers potentially noxious.
- the composition described comprises a mixture of a low viscosity linear polysiloxane having a viscosity of less than 10 centistokes, a higher viscosity linear polysiloxane having a viscosity in excess of 90 centistokes, and at least one spreading agent.
- the low viscosity polysiloxane is preferably dimethicone having a viscosity of 1 centistoke and the higher viscosity polysiloxane is preferably dimethicone having a viscosity of 100 centistokes.
- Dimethicones with a viscosity of around 1 centistoke have a flash point of the order of 57 °C and are volatile and therefore combustible. It will therefore be appreciated that in its preferred embodiment this composition is also flammable or combustible.
- pediculicidal products also suffer from the same disadvantages as described above. Some comprise blends of alcohols with siloxanes and are flammable or combustible whereas others use dimeticones that do not spread well and are hard to rinse out after use. It will be appreciated that generally a compromise has to be reached; either the composition comprises non-volatile siloxanes and is hard to rinse out or it comprises a high proportion of volatile siloxanes making the overall composition flammable or combustible and therefore hazardous.
- It is an object of the present invention is to provide an ectoparasiticidal composition which overcomes or substantially mitigates the problems associated with flammability whilst at the same time providing an ectoparasiticidal composition which can be rinsed off hair and skin after use with conventional shampoo and conditioners.
- flammable liquid and "combustible liquid” are often used loosely to mean liquids which readily catch fire.
- NFPA National Fire Protection Association
- NFPA National Fire Protection Association
- NFPA National Fire Protection Association
- these definitions are also used by US Government agencies, in particular The US Department of Transportation, the US Environmental Protection Agency, the US Occupational Safety and Health Administration and others. These bodies apply the term “flammable” to a liquid which has a flash point below 100°F (37.8°C) and the term “combustible” to less-flammable liquids which have a flash point between 100°F (37.8°C) and 200°F (93.3° C).
- the flash point of a liquid is the lowest temperature at which it can form an ignitable mixture in air. At this temperature the vapour may cease to burn when the source of ignition is removed.
- a slightly higher temperature, the fire point, is defined as the temperature at which the vapour continues to burn after being ignited. Neither of these parameters is related to the temperature of the ignition source or of the burning liquid, which are much higher.
- flash point measurement There are two basic types of flash point measurement: open cup and closed cup. Closed cup tests normally give lower values for the flash point than open cup tests and are a better approximation to the temperature at which the vapour pressure reaches a lower flammable limit. Accordingly, herein and in the appended claims the term flash point should be understood as that obtained using a Pensky-Martens closed cup method for which there are numerous international standards.
- a composition for use in the treatment or prophylaxis of a human or animal of an infestation by ectoparasites comprising a mixture of a carrier and an active with a thixotropic additive to thicken the composition when in use and with an emulsifying agent that acts as a stabilizing emulsifier with water to facilitate rinsing-off of the composition after use,
- the carrier comprising a non-volatile low viscosity siloxane having a viscosity in the range of 10 to 1000 centistokes inclusive and the active comprising a non-volatile high viscosity siloxane having a viscosity of at least 1000 centistokes, both the low viscosity siloxane and the high viscosity siloxane having a closed cup flash point of at least 100°C.
- a flash point of at least 100° C means that the siloxane in question will not form an ignitable mixture in air in normal usage of the composition.
- Siloxanes may be either linear or cyclic siloxanes.
- Non-volatile siloxanes are usually linear.
- the low viscosity siloxane and the high viscosity siloxane comprise a dimeticone or a dimeticonol or a mixture of same.
- Dimeticones are linear siloxanes of the general formula (C 2 H 6 OSi) n . They are otherwise known as polydimethylsiloxane (PDMS) and have previously been called 'dimethicone'. They are viscoelastic and their viscosity is related to their molecular weight.
- PDMS polydimethylsiloxane
- the low viscosity siloxane has a viscosity in the range of 10 to 100 centistokes inclusive and the high viscosity siloxane has a viscosity in the range of 50,000 to 200,000 centistokes inclusive.
- Dimeticones with a viscosity of 10 centistokes are available that have a closed cup flash point of around 211° C. Dimeticones with viscosities less than 10 centistokes that have a closed cup flash point of greater than 200° C are not currently commercially available. Dimeticones with viscosities in excess of 50,000 centistokes may have closed cup flash points in excess of 300°C.
- the use of these dimeticones in a composition according to the invention means that the composition does not comprise a flammable or combustible liquid and it does not, therefore, pose a fire hazard to the user. In particular, the composition is highly unlikely to enable a self-sustaining fire to arise on the hair or body in use if brought near to a naked flame. This makes the composition of the invention considerably safer to use than much of the prior art and makes it especially safe for use on children and infants.
- the composition preferably comprises at least 0.1% of the non-volatile high viscosity siloxane and may comprise up to 50% but the actual proportion used will depend on its viscosity.
- the composition itself has a viscosity in excess of 30 centistokes so that it adheres to the ectoparasites and their ova.
- the higher the viscosity of the high viscosity siloxane used the lower the proportion by volume required in the composition otherwise the composition is too viscous to use satisfactorily.
- a composition comprising a high viscosity siloxane with a viscosity in the range of 50,000 to 200,000 centistokes inclusive, then only around 4% by volume of the composition need be the high viscosity siloxane.
- a viscosity modifier in the form of a thixotropic additive is added to the basic composition to aid adhesion to the ectoparasites and their ova.
- the thixotropic additive thickens the composition when in use. It may also stabilize the composition if any physically incompatible materials are added, for example hydrophobic silicone derivatives.
- Suitable thixotropic additives will be known to those skilled in the art.
- One such is an additive in the form of silicon dioxide nano-size particles of between 7 nm and 40 nm in size.
- the composition comprises at least 0.1% and up to 0.5% by volume of the additive.
- spreading agents are used to assist in the spreadability of the composition over skin and hair. These spreading agents reduce the surface tension of the composition.
- no spreading agent is required as siloxanes can be used which have a surface tension that obviates their use.
- the siloxanes of the composition have a surface tension of the order of than 20 mN/m.
- the emulsifying agent comprises a silicone copolymer.
- the composition comprises at least 1% and preferably between 1% and 10% by volume of an emulsifying agent comprising a dimeticone copolymer, for example a 40% w/w solution of a dimeticone copolymer dispersed in cyclopentasiloxane.
- a dimeticone copolymer for example a 40% w/w solution of a dimeticone copolymer dispersed in cyclopentasiloxane.
- Such agents are readily commercially available and will be known to those skilled in the art as they are widely used in personal care products such as antiperspirants, cosmetics, shampoos and hair conditioners. They act as a stabilizing water-in-oil emulsifier and provide the rinse-off qualities required to make a composition in accordance with the invention wash off skin and hair easily and therefore make it more pleasant to use.
- the emulsifying agent itself may have a flash point less than 200°C
- compositions are modified to improve its efficacy as regards ova.
- Such a composition would have the considerable advantage that the number of treatments required for eradication of a louse infestation could be significantly reduced, in particular in the most effective compositions to a single treatment.
- the applicant has found that by adding a terpene or a phenylpropanoid derivative to siloxane compositions, whilst having no inherent insecticidal properties, the surfactant physicochemical properties of the composition are improved and that a degree of hydrophilicity is added to the overall composition. This improves the penetrating properties of the composition and permits the high viscosity siloxane to penetrate the aeropyles of the ova in addition to the spiracles of the insects, thereby improving the overall effectiveness of the composition as a whole.
- the composition comprises an essential oil or essential oils.
- the composition comprises at least 0.1% by volume of the essential oil and may comprise up to 2% by volume of the essential oil.
- the essential oil or oils comprise one or more terpenes, in particular the essential oil comprises nerolidol.
- An example of a formulation of an ectoparasiticidal composition in accordance with the invention is as follows.
- ectoparasiticidal compositions in accordance with the present invention have been developed for the convenience of particular users as liquid gel formulations for application by pouring on to the hair and as spray gel formulations for spraying onto the hair via a pump-action spray gun.
- the composition In use for the treatment of head lice, the composition should be applied to dry hair and the hair should be fully covered from roots to tip. The composition should then be left in place for at least one hour.
- Both of the examples were found to be a highly effective treatment of head lice and exhibit 100% lice kill typically within a few seconds of contact and 100% egg kill after one hour. After one hour the composition can be readily washed out with shampoo. The dead lice are washed out at the same time and can also be combed out easily. Any dead ova or nits, which are the empty egg cases, can also be removed by fingers or a fine-toothed comb. The treatment of other ectoparasites, such as fleas in animals, can be carried out in the same way.
- Lice are collected using plastic louse detection combs and transported to the laboratory within 2 hours. Lice are counted into batches that are provided with squares of nylon gauze, as a substrate upon which to stand, and each batch allocated to a marked 55 millimetre plastic Petri dish.
- Gauze squares bearing the lice are then incubated under normal maintenance conditions (30° ⁇ 2° Celsius and 50% ⁇ 15% relative humidity) for the remainder of the test period.
- the insects and gauze are washed using a bland toiletry shampoo diluted one part shampoo with fourteen parts water (FWS 1:15) after which they are rinsed using 500 millilitres of warm (35° Celsius) tap water poured through and over the gauze squares. They are then blotted dry using medical wipe tissue and incubated under normal maintenance conditions in clean plastic Petri dishes of the appropriate size until the results are recorded.
- “Moribund” describes lice that retain some movement at the time the results are scored. Such movements can range from complete physical immobility, with just small movements of the gut observable, through minor twitches of limbs, antennae or other appendages, to insects that are nearly able to crawl but are sufficiently lacking in coordination that they could not be considered as capable of continued survival. Lice in this category are also classified in the overall mortality as being no longer effectively alive.
- “Alive” describes lice that appear to walk normally and would be expected, given the opportunity to feed, to be able to continue life in a normal manner.
- the tests were performed using one replicate lice for the test formulations and one replicate for the control.
- the tests were conducted ex vivo, with an application time of 1 hour, for all of the formulations and the control.
- the aim of these tests was to demonstrate the efficacy of the three products tested against lice from the field.
- Louse eggs were obtained by providing actively laying adults with a close meshed nylon gauze as an egg laying substrate over a 48 hour period. After removal of the lice each large gauze piece was cut into a series of smaller pieces of appropriate size and bearing a suitable number of eggs. These squares were allocated on a random basis to marked 90 millimetre plastic Petri dishes.
- Gauze squares bearing the eggs were incubated under normal maintenance conditions (30° + 2° Celsius and 50% ⁇ 15% relative humidity) for the remainder of the test period, at the end of which the gauze was rinsed three times using 250 millilitres of warm (34° Celsius) tap water poured through and over the gauze squares. They were then blotted dry using medical wipe tissue and incubated under normal maintenance conditions in clean plastic Petri dishes of the appropriate size until the results were recorded. The results of tests against eggs were recorded after all the control batch had completed hatching, approximately 12 days later.
- the activity of treatments against louse eggs requires classification of the effect according to the degree of penetration of the insecticide.
- Half-hatched describes those eggs in which the louse dies during the process of emergence so that it may only manage to lift the eggshell, or else dies partially emerged from the shell.
- “Dead” Describes those eggs in which the embryo has apparently completed its development but which has not emerged from the eggshell.
- the young louse dies or is killed before or during the emergence process but before it is capable of lifting the lid from the eggshell.
- Undeveloped is a description that is applied to all those eggs that fail to develop correctly or at all. This can be identified because at the time of testing the young embryos appear amorphous inside the transparent eggshell.
- the developing embryo When the developing embryo is about 48 hours old it starts to develop a small pigmented spot at the cap end of the shell. This spot will develop to become the eye of the louse and is referred to as the "eyespot". In some cases the embryo may develop only to the point of showing an eyespot but in these cases the spot is misshapen or may even be at the wrong end of the eggshell. All such cases are classified as "Undeveloped”.
- Table 2 Formulation Exposure Time Total eggs Hatched Half-hatched Killed Underdeveloped Mortality Liquid Gel 30 Minutes 153 0 0 1 152 100% Spray Gel 30 Minutes 177 0 0 0 177 100% Liquid Gel 15 Minutes 130 0 0 14 116 100% Spray Gel 15 Minutes 136 0 0 0 136 100%
- WO2007/104345 discloses a composition comprising a mixture of a volatile dimeticone having a viscosity less than 10 centistokes and a dimeticone having a viscosity greater than 90 centistokes. However, using the same regime as indicated above in Test 2 this composition produces 82% egg kill for a one hour contact time.
- WO2010/018360 a siloxane formulation containing nerolidol is disclosed that has a most effective exposure time for egg kill of overnight although a four hour exposure period produced high levels of mortality at 92.85% compared to the overnight exposure which was 94.97%.
- the advice given to users of such formulations is to carry out two 1 hour treatments, seven days apart.
- the superior nature of the present invention is such that a cure can be achieved after a single 1 hour treatment. Indeed, the test data points to an efficacious treatment time of only around fifteen minutes being required.
- Human head lice have a unique strategy of water management. They do not produce urine, but eliminate excess water by respiratory transpiration via the trachea and spiracles. Blockage of the spiracles prevents or reduces water excretion often leading to death by gut rupture.
- X-ray analysis showed silicone present over the whole surface of a treated louse; silicone being present in dimeticone but not in lice. As shown in Fig. 1 , the silicone had formed a plug or a thin coating on the inside of the spiracles of treated lice. Ion beam cutting in the scanning electron microscope created a cross section of an abdominal spiracle as shown in Fig. 3 . X-ray spectral analysis as shown in Figs. 2 and 4 of the marked areas in Figs. 1 and 3 respectively highlights the distribution of silicon from the dimeticone.
- ectoparasiticidal formulations containing siloxanes work by blocking the spiracles of the louse thereby preventing water loss.
- Compositions in accordance with the invention work by the same mechanism.
- the images and spectrograms attached hereto show that significantly more silicone is deposited and left in the spiracles and on the surface of the lice (post washing) than with conventional compositions.
- Fig.1 a thick coating on the surface of the louse can be seen with a physical plug blocking the spiracle.
- Fig. 2 reveals the plug to be primarily silicone.
- Such a plug covering the spiracle can only be achieved by the non-volatile siloxanes used in the present formulations as they are sufficiently adhesive to the cuticle of the louse.
- Fig. 3 showing the cross-section through a spiracle reveals penetration of the composition into the spiracle as far down as the trachea.
- Fig. 4 reveals a significant quantity of silicone present within the spiracle.
- terpenoids and phenylpropanoid derivatives improve the penetrating characteristics of siloxanes into the aeropyles of the louse ovum.
- Lice eggs require oxygen/carbon dioxide gaseous exchange through their aeropyle openings in order to develop. Blocking this structure will prevent the egg from developing.
- the test results detailed above show that the liquid gel and spray formulations, which both contain nerolidol, are highly efficient at killing lice ova.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
- The present invention relates to ectoparasiticidal compositions for use in the treatment or prophylaxis of a human or animal of an infestation by ectoparasites, in particular head lice and their ova.
- Compositions for the control of ectoparasites, in particular head lice, have traditionally comprised conventional insecticides. However, many of these substances have an unpleasant odour and may cause allergic reactions. More recently non-toxic products have been found that are clinically effective. In particular, some silicone polymers, which are widely used in personal care products such as in shampoo and hair conditioners, have been found to be highly effective in eradicating both head lice and their ova when used in certain formulations.
-
US4146619 describes the use of linear alkyl or aryl siloxane polymers having a viscosity of less than about 20,000 centistokes for use as a pediculicide and/or ovicide. Such polymers are safe to use. However, it has subsequently been found that compositions comprising siloxane polymers with viscosities in excess of 20,000 centistokes are more clinically effective. -
US6683065 describes a composition for use as a pediculicide consisting of at least about 40% of polydimethylsiloxane wherein the surface tension of the composition is below about 25 dynes/centimeter at 20° C and the viscosity of the composition is above about 200 centistokes at 20° C. This composition uses the efficacy of dimeticones, but the high viscosity specified does not allow penetration of the composition through and across the surfaces of the hair. In addition, such high viscosity siloxanes have been found difficult wash out of the hair satisfactorily after use. This makes them difficult and unpleasant to use. - In contrast,
WO 01/19190 - It will be appreciated that there is no absolute definition of the term "volatile" but in a scientific context it is taken as a measure of the tendency of a substance to vaporize. Most often the term is used to describe a liquid's tendency to evaporate. One way of quantifying this is to determine a liquid's heat of vaporization, which is the energy required to vaporize a given mass of the liquid at a particular temperature. At 25 °C, the heat of vaporization of water is 2257 kJ/kg whereas that of ethanol is 840 kJ/kg. In contrast, the heat of vaporization of cyclomethicones is in the region of 157 kJ/kg, which makes them highly volatile to the extent that they exhibit no cooling effect on the skin. It will be appreciated that generally speaking the lower the heat of vaporization, the lower the flash point.
- It will be understood that viscosity can be expressed as absolute viscosity, which is measured in poises or centipoises, or as kinematic viscosity. Kinematic viscosity is the ratio of absolute viscosity to density and is measured in stokes or centistokes. For convenience herein viscosity will be expressed in centistokes unless otherwise stated. Where the density of a substance is close to 1, which is the case with dimethicones that typically have specific gravities between 0.96 and 0.98, absolute and kinematic viscosity have almost the same numerical value.
-
WO 2007104345 also describes a composition for combating ectoparasites, in particular head lice and their ova, the aim of which is to avoid the use of cyclic siloxanes that it considers potentially noxious. The composition described comprises a mixture of a low viscosity linear polysiloxane having a viscosity of less than 10 centistokes, a higher viscosity linear polysiloxane having a viscosity in excess of 90 centistokes, and at least one spreading agent. In particular, the low viscosity polysiloxane is preferably dimethicone having a viscosity of 1 centistoke and the higher viscosity polysiloxane is preferably dimethicone having a viscosity of 100 centistokes. Dimethicones with a viscosity of around 1 centistoke have a flash point of the order of 57 °C and are volatile and therefore combustible. It will therefore be appreciated that in its preferred embodiment this composition is also flammable or combustible. - In view of the foregoing, it will be appreciated that it is most important when using flammable or combustible products for the recipient being treated to keep away from naked flames, lighted cigarettes and the like. Customers may, therefore, be concerned about using such products on children.
- Other commercially available pediculicidal products also suffer from the same disadvantages as described above. Some comprise blends of alcohols with siloxanes and are flammable or combustible whereas others use dimeticones that do not spread well and are hard to rinse out after use. It will be appreciated that generally a compromise has to be reached; either the composition comprises non-volatile siloxanes and is hard to rinse out or it comprises a high proportion of volatile siloxanes making the overall composition flammable or combustible and therefore hazardous.
- It is an object of the present invention is to provide an ectoparasiticidal composition which overcomes or substantially mitigates the problems associated with flammability whilst at the same time providing an ectoparasiticidal composition which can be rinsed off hair and skin after use with conventional shampoo and conditioners.
- The terms "flammable liquid" and "combustible liquid" are often used loosely to mean liquids which readily catch fire. However, herein the terms "flammable" and "combustible" are to be understood using the precise definitions applied to them by the National Fire Protection Association (NFPA) which is an internationally recognized US body concerned with fire safety. These definitions are also used by US Government agencies, in particular The US Department of Transportation, the US Environmental Protection Agency, the US Occupational Safety and Health Administration and others. These bodies apply the term "flammable" to a liquid which has a flash point below 100°F (37.8°C) and the term "combustible" to less-flammable liquids which have a flash point between 100°F (37.8°C) and 200°F (93.3° C). The flash point of a liquid is the lowest temperature at which it can form an ignitable mixture in air. At this temperature the vapour may cease to burn when the source of ignition is removed. A slightly higher temperature, the fire point, is defined as the temperature at which the vapour continues to burn after being ignited. Neither of these parameters is related to the temperature of the ignition source or of the burning liquid, which are much higher.
- There are two basic types of flash point measurement: open cup and closed cup. Closed cup tests normally give lower values for the flash point than open cup tests and are a better approximation to the temperature at which the vapour pressure reaches a lower flammable limit. Accordingly, herein and in the appended claims the term flash point should be understood as that obtained using a Pensky-Martens closed cup method for which there are numerous international standards.
- Surprisingly, the applicant has found that the use of a non-volatile low viscosity siloxane will act to spread a non-volatile high viscosity siloxane and that evaporation of the low viscosity siloxane is not required for the efficacy of the product.
- Thus, according to the present invention there is provided a composition for use in the treatment or prophylaxis of a human or animal of an infestation by ectoparasites comprising a mixture of a carrier and an active with a thixotropic additive to thicken the composition when in use and with an emulsifying agent that acts as a stabilizing emulsifier with water to facilitate rinsing-off of the composition after use, the carrier comprising a non-volatile low viscosity siloxane having a viscosity in the range of 10 to 1000 centistokes inclusive and the active comprising a non-volatile high viscosity siloxane having a viscosity of at least 1000 centistokes, both the low viscosity siloxane and the high viscosity siloxane having a closed cup flash point of at least 100°C.
- A flash point of at least 100° C means that the siloxane in question will not form an ignitable mixture in air in normal usage of the composition.
- Siloxanes may be either linear or cyclic siloxanes. Non-volatile siloxanes are usually linear. Preferably, the low viscosity siloxane and the high viscosity siloxane comprise a dimeticone or a dimeticonol or a mixture of same.
- Dimeticones are linear siloxanes of the general formula (C2H6OSi) n . They are otherwise known as polydimethylsiloxane (PDMS) and have previously been called 'dimethicone'. They are viscoelastic and their viscosity is related to their molecular weight.
- Advantageously, the low viscosity siloxane has a viscosity in the range of 10 to 100 centistokes inclusive and the high viscosity siloxane has a viscosity in the range of 50,000 to 200,000 centistokes inclusive.
- Dimeticones with a viscosity of 10 centistokes are available that have a closed cup flash point of around 211° C. Dimeticones with viscosities less than 10 centistokes that have a closed cup flash point of greater than 200° C are not currently commercially available. Dimeticones with viscosities in excess of 50,000 centistokes may have closed cup flash points in excess of 300°C. The use of these dimeticones in a composition according to the invention means that the composition does not comprise a flammable or combustible liquid and it does not, therefore, pose a fire hazard to the user. In particular, the composition is highly unlikely to enable a self-sustaining fire to arise on the hair or body in use if brought near to a naked flame. This makes the composition of the invention considerably safer to use than much of the prior art and makes it especially safe for use on children and infants.
- The composition preferably comprises at least 0.1% of the non-volatile high viscosity siloxane and may comprise up to 50% but the actual proportion used will depend on its viscosity. Preferably, the composition itself has a viscosity in excess of 30 centistokes so that it adheres to the ectoparasites and their ova. Generally speaking, the higher the viscosity of the high viscosity siloxane used, the lower the proportion by volume required in the composition otherwise the composition is too viscous to use satisfactorily. In a composition comprising a high viscosity siloxane with a viscosity in the range of 50,000 to 200,000 centistokes inclusive, then only around 4% by volume of the composition need be the high viscosity siloxane.
- A viscosity modifier in the form of a thixotropic additive is added to the basic composition to aid adhesion to the ectoparasites and their ova. The thixotropic additive thickens the composition when in use. It may also stabilize the composition if any physically incompatible materials are added, for example hydrophobic silicone derivatives. Suitable thixotropic additives will be known to those skilled in the art. One such is an additive in the form of silicon dioxide nano-size particles of between 7 nm and 40 nm in size. Preferably, the composition comprises at least 0.1% and up to 0.5% by volume of the additive.
- In some prior art compositions, spreading agents are used to assist in the spreadability of the composition over skin and hair. These spreading agents reduce the surface tension of the composition. However, in the present invention no spreading agent is required as siloxanes can be used which have a surface tension that obviates their use. Advantageously, therefore, the siloxanes of the composition have a surface tension of the order of than 20 mN/m.
- Preferably also, the emulsifying agent comprises a silicone copolymer. Advantageously, the composition comprises at least 1% and preferably between 1% and 10% by volume of an emulsifying agent comprising a dimeticone copolymer, for example a 40% w/w solution of a dimeticone copolymer dispersed in cyclopentasiloxane. Such agents are readily commercially available and will be known to those skilled in the art as they are widely used in personal care products such as antiperspirants, cosmetics, shampoos and hair conditioners. They act as a stabilizing water-in-oil emulsifier and provide the rinse-off qualities required to make a composition in accordance with the invention wash off skin and hair easily and therefore make it more pleasant to use. While the emulsifying agent itself may have a flash point less than 200°C, the small quantity of emulsifying agent required in the composition does not compromise its overall flammability.
- While mixtures of siloxanes are extremely effective in killing lice and fleas, their ova are more difficult to kill and may survive to cause reinfection after treatment. Preferably, therefore, the composition is modified to improve its efficacy as regards ova. Such a composition would have the considerable advantage that the number of treatments required for eradication of a louse infestation could be significantly reduced, in particular in the most effective compositions to a single treatment.
- The applicant has found that by adding a terpene or a phenylpropanoid derivative to siloxane compositions, whilst having no inherent insecticidal properties, the surfactant physicochemical properties of the composition are improved and that a degree of hydrophilicity is added to the overall composition. This improves the penetrating properties of the composition and permits the high viscosity siloxane to penetrate the aeropyles of the ova in addition to the spiracles of the insects, thereby improving the overall effectiveness of the composition as a whole.
- Preferably, therefore, the composition comprises an essential oil or essential oils. Preferably also, the composition comprises at least 0.1% by volume of the essential oil and may comprise up to 2% by volume of the essential oil. Advantageously, the essential oil or oils comprise one or more terpenes, in particular the essential oil comprises nerolidol.
- An example of a formulation of an ectoparasiticidal composition in accordance with the invention is as follows.
- 1. 4% by volume of a dimeticone having a viscosity of 100,000 centistokes;
- 2. between 1% and 4% by volume of an emulsifying agent comprising a dimeticone copolymer;
- 3. up to 2% by volume of nerolidol;
- 4. up to 0.5% by volume of silicon dioxide nano-size particles; and
- 5. a balance of a dimeticone having a viscosity of between 10 and 100 centistokes.
- In particular, ectoparasiticidal compositions in accordance with the present invention have been developed for the convenience of particular users as liquid gel formulations for application by pouring on to the hair and as spray gel formulations for spraying onto the hair via a pump-action spray gun.
- Specific examples of these formulations are as follows.
-
- 1. 4% by volume of a dimeticone having a viscosity of 100,000 centistokes;
- 2. 2% by volume of a dimeticone copolymer;
- 3. 2% by volume of nerolidol;
- 4. 0.5% by volume of silicon dioxide nano-size particles; and
- 5. 91.5% balance of dimeticone having a viscosity of 50 centistokes.
-
- 1. 4% by volume of a dimeticone having a viscosity of 100,000 centistokes;
- 2. 2% by volume of a dimeticone copolymer;
- 3. 2% by volume of nerolidol;
- 4. 0.5% by volume of silicon dioxide nano-size particles; and
- 5. 91.5% balance of a dimeticone having a viscosity of 10 centistokes.
- It will be appreciated that the only difference between these formulations is the viscosity of the dimeticone carrier, which in the spray gel formulation has a lower viscosity for ease of application via a pump action spray gun.
- In use for the treatment of head lice, the composition should be applied to dry hair and the hair should be fully covered from roots to tip. The composition should then be left in place for at least one hour.
- Both of the examples were found to be a highly effective treatment of head lice and exhibit 100% lice kill typically within a few seconds of contact and 100% egg kill after one hour. After one hour the composition can be readily washed out with shampoo. The dead lice are washed out at the same time and can also be combed out easily. Any dead ova or nits, which are the empty egg cases, can also be removed by fingers or a fine-toothed comb. The treatment of other ectoparasites, such as fleas in animals, can be carried out in the same way.
- The following tests illustrate the invention.
- This test compared the efficacy against head lice of a conventional siloxane based product as described in
WO01/19190 - Head lice, Pediculus capitis, were obtained from volunteers from the community. As a result lice used in the tests were obtained from different sources. On each day of testing all of the samples were evaluated once. For each of the tests performed on the same day all of the lice were obtained from the same individual patient so there was an internal consistency within a batch of test replicates. As only one replicate test of each formulation was performed on any one day there could have been some variation between tests conducted on different days. However, this would have represented the normal variation of head lice likely to be encountered in the community and any variation of response would be representative of the range of response likely to be encountered in consumer use.
- Lice are collected using plastic louse detection combs and transported to the laboratory within 2 hours. Lice are counted into batches that are provided with squares of nylon gauze, as a substrate upon which to stand, and each batch allocated to a marked 55 millimetre plastic Petri dish.
- For the test procedure an aliquot of approximately 5-10 millilitres of the appropriate formulation is poured into the base of a clean 55 millimetre plastic Petri dish. The gauze bearing the lice is immersed in the fluid for 10 seconds, during which time the gauze is turned at least twice to ensure removal of air bubbles. After removal from the fluid the gauze and insects are lightly blotted to remove excess fluid and returned to a 5.5 mm filter paper in their marked Petri dish. The same procedure is repeated for the other replicate gauze squares in that batch.
- Gauze squares bearing the lice are then incubated under normal maintenance conditions (30° ± 2° Celsius and 50% ± 15% relative humidity) for the remainder of the test period. At the end of exposure period the insects and gauze are washed using a bland toiletry shampoo diluted one part shampoo with fourteen parts water (FWS 1:15) after which they are rinsed using 500 millilitres of warm (35° Celsius) tap water poured through and over the gauze squares. They are then blotted dry using medical wipe tissue and incubated under normal maintenance conditions in clean plastic Petri dishes of the appropriate size until the results are recorded.
- "Immobile" lice showing no signs of movement.
- "Moribund" describes lice that retain some movement at the time the results are scored. Such movements can range from complete physical immobility, with just small movements of the gut observable, through minor twitches of limbs, antennae or other appendages, to insects that are nearly able to crawl but are sufficiently lacking in coordination that they could not be considered as capable of continued survival. Lice in this category are also classified in the overall mortality as being no longer effectively alive.
- "Alive" describes lice that appear to walk normally and would be expected, given the opportunity to feed, to be able to continue life in a normal manner.
- The tests were performed using one replicate lice for the test formulations and one replicate for the control. The tests were conducted ex vivo, with an application time of 1 hour, for all of the formulations and the control. The aim of these tests was to demonstrate the efficacy of the three products tested against lice from the field.
- The results of the tests are shown in Table 1 below. The efficacy of the formulations is shown after a ten second dip and then an immediate wash off and a further set of tests is shown with a ten minute application and then wash off. These tests are to show whether either of the formulations has an immediate effect on the lice, and whether a ten minute application is successful at immobilising the lice.
Table 1 Results 1 hour after washing off Formulation Exposure Immobile Morbid Alive Total Mortality % A 10 minutes 14 0 0 14 100% B 10 minutes 13 0 0 13 100% A 10 second dip / wash off 5 0 0 5 100% B 10 second dip / wash off 5 0 0 5 100% Control 1 hour 0 0 15 15 0% Results 2 hours after washing off Formulation Exposure Immobile Morbid Alive Total Mortality % A 10 minutes 14 0 0 14 100% B 10 minutes 13 0 0 13 100% A 10 second dip / wash off 5 0 0 5 100% B 10 second dip / wash off 5 0 0 5 100% Control 1 hour 0 0 15 15 0% Results 3 hours after washing off Formulation Exposure Immobile Morbid Alive Total Mortality % A 10 minutes 14 0 0 14 100% B 10 minutes 13 0 0 13 100% A 10 second dip / wash off 5 0 0 5 100% B 10 second dip / wash off 5 0 0 5 100% Control 1 hour 1 0 14 15 0% Results 17 hours after washing off Formulation Exposure Dead Morbid Alive Total Mortality % B 10 minutes 13 0 0 13 100% A 10 second dip / wash off 5 0 0 5 100% B 10 second dip / wash off 5 0 0 5 100% Control 1 hour 3 0 12 15 20% - These test results show that a composition in accordance with the present invention is successful at instantly immobilizing lice after both exposure times.
- This test compared the efficacy against head lice ova of the liquid gel formulation and the spray gel formulation, both as detailed above, at two different exposure times. The two formulations were tested with exposure times of 15 minutes and 30 minutes
- Louse eggs were obtained by providing actively laying adults with a close meshed nylon gauze as an egg laying substrate over a 48 hour period. After removal of the lice each large gauze piece was cut into a series of smaller pieces of appropriate size and bearing a suitable number of eggs. These squares were allocated on a random basis to marked 90 millimetre plastic Petri dishes.
- For the test an aliquot of approximately 5 millilitres of the appropriate fluid was poured into the base of a clean 30 millimetre plastic Petri dish. The gauze bearing the eggs was immersed in the liquid for 10 seconds, during which time the gauze was turned at least twice to ensure removal of air bubbles. After removal from the fluid the gauze and eggs were lightly blotted to remove any excess and returned to their marked Petri dish. The same procedure was repeated for the other test products and the water control.
- Gauze squares bearing the eggs were incubated under normal maintenance conditions (30° + 2° Celsius and 50% ± 15% relative humidity) for the remainder of the test period, at the end of which the gauze was rinsed three times using 250 millilitres of warm (34° Celsius) tap water poured through and over the gauze squares. They were then blotted dry using medical wipe tissue and incubated under normal maintenance conditions in clean plastic Petri dishes of the appropriate size until the results were recorded. The results of tests against eggs were recorded after all the control batch had completed hatching, approximately 12 days later.
- The activity of treatments against louse eggs requires classification of the effect according to the degree of penetration of the insecticide.
- "Hatched" describes louse eggs in which the embryo inside develops normally and hatches normally.
- "Half-hatched" describes those eggs in which the louse dies during the process of emergence so that it may only manage to lift the eggshell, or else dies partially emerged from the shell.
- "Dead" Describes those eggs in which the embryo has apparently completed its development but which has not emerged from the eggshell. The young louse dies or is killed before or during the emergence process but before it is capable of lifting the lid from the eggshell.
- "Undeveloped" is a description that is applied to all those eggs that fail to develop correctly or at all. This can be identified because at the time of testing the young embryos appear amorphous inside the transparent eggshell. When the developing embryo is about 48 hours old it starts to develop a small pigmented spot at the cap end of the shell. This spot will develop to become the eye of the louse and is referred to as the "eyespot". In some cases the embryo may develop only to the point of showing an eyespot but in these cases the spot is misshapen or may even be at the wrong end of the eggshell. All such cases are classified as "Undeveloped".
- The results of the tests are shown in Table 2.
Table 2 Formulation Exposure Time Total eggs Hatched Half-hatched Killed Underdeveloped Mortality Liquid Gel 30 Minutes 153 0 0 1 152 100% Spray Gel 30 Minutes 177 0 0 0 177 100% Liquid Gel 15 Minutes 130 0 0 14 116 100% Spray Gel 15 Minutes 136 0 0 0 136 100% - These results clearly demonstrate the efficacy of both formulations against louse ova at the different exposure times. Both produced 100% mortality with the 15 and 30 minute exposure times.
- It will be seen from the test data above that the aforementioned liquid gel and spray gel formulations have been found to exhibit 100% lice kill on contact, typically within ten to fifteen seconds, and 100% egg kill after as little as fifteen minutes. This is a dramatic improvement over known formulations using siloxanes.
WO2007/104345 discloses a composition comprising a mixture of a volatile dimeticone having a viscosity less than 10 centistokes and a dimeticone having a viscosity greater than 90 centistokes. However, using the same regime as indicated above in Test 2 this composition produces 82% egg kill for a one hour contact time. InWO2010/018360 a siloxane formulation containing nerolidol is disclosed that has a most effective exposure time for egg kill of overnight although a four hour exposure period produced high levels of mortality at 92.85% compared to the overnight exposure which was 94.97%. Typically, therefore, the advice given to users of such formulations is to carry out two 1 hour treatments, seven days apart. However, the superior nature of the present invention is such that a cure can be achieved after a single 1 hour treatment. Indeed, the test data points to an efficacious treatment time of only around fifteen minutes being required. - Human head lice have a unique strategy of water management. They do not produce urine, but eliminate excess water by respiratory transpiration via the trachea and spiracles. Blockage of the spiracles prevents or reduces water excretion often leading to death by gut rupture.
- Lice treated with the liquid gel formulation detailed above were scanned in a scanning electron microscope by x-ray spectroscopy and the chemical elements found in and around the spiracles of the lice were determined by cutting the surrounding tissues away using a focused ion beam and x-ray microanalysis. The results are shown in the attached drawings in which
-
Fig. 1 is a photograph of an image produced by a scanning electron microscope of a spiracle of a human head louse after treatment with the liquid gel formulation detailed above; -
Fig. 2 is an x-ray spectrogram of the marked area inFig.1 ; -
Fig. 3 is a photograph of an image produced by a scanning electron microscope of a cross-section through a spiracle of a human head louse after treatment with the liquid gel formulation detailed above; and -
Fig. 4 is an x-ray spectrogram of the marked area inFig. 3 . - X-ray analysis showed silicone present over the whole surface of a treated louse; silicone being present in dimeticone but not in lice. As shown in
Fig. 1 , the silicone had formed a plug or a thin coating on the inside of the spiracles of treated lice. Ion beam cutting in the scanning electron microscope created a cross section of an abdominal spiracle as shown inFig. 3 . X-ray spectral analysis as shown inFigs. 2 and4 of the marked areas inFigs. 1 and3 respectively highlights the distribution of silicon from the dimeticone. - It is known that ectoparasiticidal formulations containing siloxanes work by blocking the spiracles of the louse thereby preventing water loss. Compositions in accordance with the invention work by the same mechanism. However, the images and spectrograms attached hereto show that significantly more silicone is deposited and left in the spiracles and on the surface of the lice (post washing) than with conventional compositions. In
Fig.1 a thick coating on the surface of the louse can be seen with a physical plug blocking the spiracle.Fig. 2 reveals the plug to be primarily silicone. Such a plug covering the spiracle can only be achieved by the non-volatile siloxanes used in the present formulations as they are sufficiently adhesive to the cuticle of the louse. Similarly,Fig. 3 showing the cross-section through a spiracle reveals penetration of the composition into the spiracle as far down as the trachea.Fig. 4 reveals a significant quantity of silicone present within the spiracle. These images and spectrograms explain the superior performance of compositions in accordance with the invention. In contrast, conventional siloxane compositions rely on very low viscosity, very low surface tension siloxane formulations that spread out thinly over the louse cuticle. - As regards the killing of head lice ova, as disclosed in
WO2010/018360 it is thought that terpenoids and phenylpropanoid derivatives, and in particular linear terpenoids such as nerolidol, improve the penetrating characteristics of siloxanes into the aeropyles of the louse ovum. Lice eggs require oxygen/carbon dioxide gaseous exchange through their aeropyle openings in order to develop. Blocking this structure will prevent the egg from developing. The test results detailed above show that the liquid gel and spray formulations, which both contain nerolidol, are highly efficient at killing lice ova. While it is expected that nerolidol will improve the penetration of the siloxanes of compositions in accordance with the present invention into the aeropyles of the ova, it is also thought that the non-volatile siloxanes used in these compositions form plugs over the aeropyles in the same way as over the spiracles, effectively blocking them without necessarily needing to penetrate deeply into the aeropyle. This explains why the ova are killed very quickly.
Claims (14)
- A composition for use in the treatment or prophylaxis of a human or animal of an infestation by ectoparasites comprising a mixture of a carrier and an active with a thixotropic additive to thicken the composition when in use and with an emulsifying agent that acts as a stabilizing emulsifier with water to facilitate rinsing-off of the composition after use, the carrier comprising a non-volatile low viscosity siloxane having a viscosity in the range of 10 to 1000 centistokes inclusive and the active comprising a non-volatile high viscosity siloxane having a viscosity of at least 1000 centistokes, both the low viscosity siloxane and the high viscosity siloxane having a closed cup flash point of at least 100°C.
- A composition for use according to Claim 1, wherein both the low viscosity siloxane and the high viscosity siloxane comprise a dimeticone or a dimeticonol or a mixture of same.
- A composition for use according to Claim 1 or Claim 2, wherein the mixture has a viscosity in excess of 30 centistokes.
- A composition for use according to any of Claims 1 to 3, wherein the emulsifying agent comprises a silicone copolymer.
- A composition for use according to Claim 4, comprising at least 1% by volume of the silicone copolymer.
- A composition for use according to Claim 4 or Claim 5, comprising between 1% and 10% by volume of the silicone copolymer.
- A composition for use according to any of Claims 1 to 6, wherein the emulsifying agent comprises a 40% w/w solution of a dimeticone copolymer dispersed in cyclopentasiloxane.
- A composition for use according to any of Claims 1 to 7, wherein the low viscosity siloxane has a viscosity in the range of 10 to 100 centistokes inclusive and the high viscosity siloxane has a viscosity in the range of 50,000 to 200,000 centistokes inclusive.
- A composition for use according to any of Claims 1 to 8, wherein the high viscosity siloxane comprises at least 0.1% by volume of the composition.
- A composition for use according to any of Claims 1 to 9, comprising an essential oil or essential oils at at least 0.1% by volume of the composition.
- A composition for use according to Claim 10, wherein the essential oil or oils comprise one or more terpenes.
- A composition for use according to Claim 10 or Claim 11, wherein the essential oil comprises nerolidol.
- A composition for use according to any of Claims 1 to 12, comprising4% by volume of a dimeticone having a viscosity of 100,000 centistokes;between 1% and 4% by volume of an emulsifying agent comprising a dimeticone copolymer;up to 2% by volume of nerolidol;up to 0.5% by volume of a thixotropic additive comprised of silicon dioxide nano-size particles; anda balance of a dimeticone having a viscosity of between 10 and 100 centistokes.
- A composition for use according to any of Claims 1 to 12, wherein the thixotropic additive comprises silicon dioxide nano-size particles and is at least 0.1% by volume of the composition.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL10718271T PL2429284T3 (en) | 2009-05-14 | 2010-05-12 | A method and composition for the control of ectoparasites |
SI201031490A SI2429284T1 (en) | 2009-05-14 | 2010-05-12 | A method and composition for the control of ectoparasites |
HRP20170764TT HRP20170764T1 (en) | 2009-05-14 | 2017-05-22 | A method and composition for the control of ectoparasites |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0908226.4A GB2470208B (en) | 2009-05-14 | 2009-05-14 | A method and composition for the control of ectoparasites |
GBGB0912209.4A GB0912209D0 (en) | 2009-05-14 | 2009-07-14 | A method and composition for the control of ectoparasites |
PCT/GB2010/000933 WO2010130983A1 (en) | 2009-05-14 | 2010-05-12 | A method and composition for the control of ectoparasites |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2429284A1 EP2429284A1 (en) | 2012-03-21 |
EP2429284B1 true EP2429284B1 (en) | 2017-04-12 |
Family
ID=40833932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10718271.9A Active EP2429284B1 (en) | 2009-05-14 | 2010-05-12 | A method and composition for the control of ectoparasites |
Country Status (38)
Country | Link |
---|---|
US (1) | US8530451B2 (en) |
EP (1) | EP2429284B1 (en) |
JP (1) | JP5793492B2 (en) |
KR (1) | KR101698624B1 (en) |
CN (1) | CN102427820B (en) |
AU (1) | AU2010247151B2 (en) |
CA (1) | CA2759546C (en) |
CL (1) | CL2011002856A1 (en) |
CO (1) | CO6470884A2 (en) |
CR (1) | CR20110597A (en) |
CY (1) | CY1119274T1 (en) |
DE (1) | DE112010001992B4 (en) |
DK (2) | DK2429284T3 (en) |
EA (1) | EA020179B1 (en) |
EC (1) | ECSP11011505A (en) |
ES (2) | ES2628819T3 (en) |
FR (1) | FR2945447B1 (en) |
GB (2) | GB2470208B (en) |
GE (1) | GEP20135968B (en) |
HK (1) | HK1167813A1 (en) |
HR (1) | HRP20170764T1 (en) |
HU (1) | HUE035165T2 (en) |
IL (1) | IL215837A (en) |
LT (1) | LT2429284T (en) |
MX (1) | MX2011012145A (en) |
MY (1) | MY152966A (en) |
NI (1) | NI201100201A (en) |
NZ (1) | NZ596526A (en) |
PE (2) | PE20170204A1 (en) |
PL (1) | PL2429284T3 (en) |
PT (1) | PT2429284T (en) |
SE (1) | SE537567C2 (en) |
SG (1) | SG175369A1 (en) |
SI (1) | SI2429284T1 (en) |
TN (1) | TN2011000546A1 (en) |
UA (1) | UA107460C2 (en) |
WO (1) | WO2010130983A1 (en) |
ZA (1) | ZA201108348B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1020154A5 (en) * | 2012-03-22 | 2013-05-07 | Omega Pharma Innovation & Dev Nv | COMPOSITION FOR THE TREATMENT OF PEDICULOSIS AND ACCORDING TO A PRODUCTION METHOD. |
AU2013204386B2 (en) * | 2012-11-01 | 2016-04-14 | Intervet International B.V. | Topical parasiticidal formulation |
CA3021394C (en) * | 2016-02-04 | 2021-12-28 | Gordon Wayne Dyer | Method for breaching an oleo and hydro resistant arthropod plastron by applying a low molecular weight non-polar chemical breacher to the plastron |
US10334853B2 (en) | 2016-03-29 | 2019-07-02 | Larada Sciences | Compositions and methods for treating ectoparasite infestation |
JP2019081752A (en) * | 2017-10-30 | 2019-05-30 | アース製薬株式会社 | Method of inhibiting colonization by blood-sucking pests and colonization inhibitor against blood-sucking pests |
US10328112B2 (en) | 2017-11-29 | 2019-06-25 | Michael S. Hatten | Abrasive pediculicide compositions comprising materials, kits, and methods of use |
WO2019161433A1 (en) * | 2018-02-21 | 2019-08-29 | Michael Lawless Atf The Lawless Family Trust | Head lice applicator |
GB2574022A (en) | 2018-05-22 | 2019-11-27 | Thornton & Ross Ltd | A pediculicidal shampoo |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5906961A (en) * | 1997-05-29 | 1999-05-25 | Helena Chemical Company | Alkanolamide spreader-sticker surfactant combination |
WO2003039508A1 (en) * | 2001-11-07 | 2003-05-15 | Beiersdorf Ag | Low-viscosity, sprayable w/o emulsions |
WO2004039338A1 (en) * | 2002-10-31 | 2004-05-13 | Merz Pharma Gmbh & Co. Kgaa | O/w emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use therof |
WO2006063730A1 (en) * | 2004-12-15 | 2006-06-22 | Wacker Chemie Ag | Manufacture of stable silicone emulsion |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4146619A (en) * | 1977-05-31 | 1979-03-27 | Block Drug Company Inc. | Siloxane toxicants |
AU7656891A (en) * | 1990-04-18 | 1991-11-11 | Procter & Gamble Company, The | Anti-lice treatment compositions |
JPH0733630A (en) | 1993-07-19 | 1995-02-03 | Kao Corp | Hair treatment composition |
TW513309B (en) * | 1998-07-01 | 2002-12-11 | Kao Corp | Powder-based solid cosmetic composition and preparation process thereof |
IL148138A0 (en) * | 1999-08-19 | 2002-09-12 | Holzer David | Method of treating body insect infestation |
US6683065B1 (en) | 1999-08-19 | 2004-01-27 | Host Pharmaceuticals Llc | Method of treating body insect infestation |
DK1215965T3 (en) | 1999-09-16 | 2004-02-16 | Durminster Ltd | Method and Preparation for Combating Arthropods |
GB0106507D0 (en) * | 2001-03-16 | 2001-05-02 | Entomos Sciences Ltd | Arthropodicidal compositions |
FR2823101B1 (en) * | 2001-04-10 | 2004-02-06 | Oreal | TWO-LAYER MAKEUP PRODUCT, USES THEREOF AND MAKEUP KIT CONTAINING THIS PRODUCT |
US6663876B2 (en) * | 2002-04-29 | 2003-12-16 | Piedmont Pharmaceuticals, Llc | Methods and compositions for treating ectoparasite infestation |
JP4543799B2 (en) * | 2004-07-14 | 2010-09-15 | 栗田工業株式会社 | Water quality evaluation method, ultrapure water evaluation apparatus and ultrapure water production system using the method |
DE202006004172U1 (en) * | 2006-03-13 | 2006-05-11 | G. Pohl-Boskamp Gmbh & Co. Kg | Means of combating ectoparasites and their eggs |
GB0814713D0 (en) * | 2008-08-12 | 2008-09-17 | Thornton & Ross Ltd | A method and composition for the control of ectoparasites |
DE102009034704A1 (en) * | 2009-07-24 | 2011-01-27 | G. Pohl-Boskamp Gmbh & Co. Kg | Agent for combating ectoparasites |
-
2009
- 2009-05-14 GB GB0908226.4A patent/GB2470208B/en active Active
- 2009-07-14 GB GBGB0912209.4A patent/GB0912209D0/en not_active Ceased
- 2009-08-04 FR FR0955492A patent/FR2945447B1/en active Active
-
2010
- 2010-05-12 SG SG2011078847A patent/SG175369A1/en unknown
- 2010-05-12 US US13/266,230 patent/US8530451B2/en active Active
- 2010-05-12 HU HUE10718271A patent/HUE035165T2/en unknown
- 2010-05-12 PL PL10718271T patent/PL2429284T3/en unknown
- 2010-05-12 ES ES10718271.9T patent/ES2628819T3/en active Active
- 2010-05-12 CN CN201080021463.6A patent/CN102427820B/en active Active
- 2010-05-12 PE PE2016002206A patent/PE20170204A1/en unknown
- 2010-05-12 EP EP10718271.9A patent/EP2429284B1/en active Active
- 2010-05-12 EA EA201171407A patent/EA020179B1/en unknown
- 2010-05-12 DE DE112010001992.4T patent/DE112010001992B4/en active Active
- 2010-05-12 AU AU2010247151A patent/AU2010247151B2/en active Active
- 2010-05-12 CA CA2759546A patent/CA2759546C/en active Active
- 2010-05-12 DK DK10718271.9T patent/DK2429284T3/en active
- 2010-05-12 SI SI201031490A patent/SI2429284T1/en unknown
- 2010-05-12 LT LTEP10718271.9T patent/LT2429284T/en unknown
- 2010-05-12 GE GEAP201012500A patent/GEP20135968B/en unknown
- 2010-05-12 PE PE2011001944A patent/PE20120905A1/en not_active Application Discontinuation
- 2010-05-12 NZ NZ596526A patent/NZ596526A/en unknown
- 2010-05-12 SE SE1100883A patent/SE537567C2/en unknown
- 2010-05-12 KR KR1020117029808A patent/KR101698624B1/en active IP Right Grant
- 2010-05-12 MY MYPI2011005346 patent/MY152966A/en unknown
- 2010-05-12 UA UAA201114834A patent/UA107460C2/en unknown
- 2010-05-12 ES ES201190070A patent/ES2380713B2/en active Active
- 2010-05-12 JP JP2012510358A patent/JP5793492B2/en active Active
- 2010-05-12 MX MX2011012145A patent/MX2011012145A/en active IP Right Grant
- 2010-05-12 WO PCT/GB2010/000933 patent/WO2010130983A1/en active Application Filing
- 2010-05-12 PT PT107182719T patent/PT2429284T/en unknown
-
2011
- 2011-10-23 IL IL215837A patent/IL215837A/en active IP Right Grant
- 2011-10-26 TN TNP2011000546A patent/TN2011000546A1/en unknown
- 2011-11-14 CL CL2011002856A patent/CL2011002856A1/en unknown
- 2011-11-14 NI NI201100201A patent/NI201100201A/en unknown
- 2011-11-14 ZA ZA2011/08348A patent/ZA201108348B/en unknown
- 2011-11-14 CR CR20110597A patent/CR20110597A/en unknown
- 2011-12-02 DK DK201170667A patent/DK177899B1/en active
- 2011-12-08 EC ECSP11011505 patent/ECSP11011505A/en unknown
- 2011-12-12 CO CO11170786A patent/CO6470884A2/en active IP Right Grant
-
2012
- 2012-08-30 HK HK12108503.9A patent/HK1167813A1/en unknown
-
2017
- 2017-05-22 HR HRP20170764TT patent/HRP20170764T1/en unknown
- 2017-06-23 CY CY20171100672T patent/CY1119274T1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5906961A (en) * | 1997-05-29 | 1999-05-25 | Helena Chemical Company | Alkanolamide spreader-sticker surfactant combination |
WO2003039508A1 (en) * | 2001-11-07 | 2003-05-15 | Beiersdorf Ag | Low-viscosity, sprayable w/o emulsions |
WO2004039338A1 (en) * | 2002-10-31 | 2004-05-13 | Merz Pharma Gmbh & Co. Kgaa | O/w emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use therof |
WO2006063730A1 (en) * | 2004-12-15 | 2006-06-22 | Wacker Chemie Ag | Manufacture of stable silicone emulsion |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2429284B1 (en) | A method and composition for the control of ectoparasites | |
US20190380350A1 (en) | Topical mosquito control product with sunscreen | |
EP3174391B1 (en) | Siloxane-free liquid spreading composition comprising isopropylmyristate and isohexadecane for combating ectoparasites | |
GB2462526A (en) | A composition for the control of ectoparasites | |
BRPI1007769B1 (en) | METHOD AND COMPOSITION FOR CONTROL OF ECTOPARATISTS | |
KR102212590B1 (en) | Natural pesticide composition harmless to human body and manufacturing method thereof | |
CZ2017210A3 (en) | A composition for killing lice | |
CZ31201U1 (en) | A preparation for lice extermination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20111208 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20130411 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20161128 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 882949 Country of ref document: AT Kind code of ref document: T Effective date: 20170515 Ref country code: RO Ref legal event code: EPE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010041469 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: TUEP Ref document number: P20170764 Country of ref document: HR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: KIRKER AND CIE S.A., CH |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20170626 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Ref document number: 2429284 Country of ref document: PT Date of ref document: 20170718 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20170712 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2628819 Country of ref document: ES Kind code of ref document: T3 Effective date: 20170804 |
|
REG | Reference to a national code |
Ref country code: EE Ref legal event code: FG4A Ref document number: E013838 Country of ref document: EE Effective date: 20170616 |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20170412 |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: T1PR Ref document number: P20170764 Country of ref document: HR |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20170401793 Country of ref document: GR Effective date: 20171122 |
|
REG | Reference to a national code |
Ref country code: SK Ref legal event code: T3 Ref document number: E 24786 Country of ref document: SK |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010041469 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170412 |
|
26N | No opposition filed |
Effective date: 20180115 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E035165 Country of ref document: HU |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: ODRP Ref document number: P20170764 Country of ref document: HR Payment date: 20190507 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 882949 Country of ref document: AT Kind code of ref document: T Effective date: 20170412 |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: ODRP Ref document number: P20170764 Country of ref document: HR Payment date: 20200504 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190512 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: WAGNER + HELBIG PATENTANWAELTE CONSEILS EN PROP, CH |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: ODRP Ref document number: P20170764 Country of ref document: HR Payment date: 20210503 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: ODRP Ref document number: P20170764 Country of ref document: HR Payment date: 20220511 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: ODRP Ref document number: P20170764 Country of ref document: HR Payment date: 20230421 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20230315 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: RO Payment date: 20230428 Year of fee payment: 14 Ref country code: PT Payment date: 20230421 Year of fee payment: 14 Ref country code: NO Payment date: 20230519 Year of fee payment: 14 Ref country code: IT Payment date: 20230525 Year of fee payment: 14 Ref country code: FR Payment date: 20230523 Year of fee payment: 14 Ref country code: EE Payment date: 20230523 Year of fee payment: 14 Ref country code: CY Payment date: 20230426 Year of fee payment: 14 Ref country code: BG Payment date: 20230525 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20230425 Year of fee payment: 14 Ref country code: SK Payment date: 20230424 Year of fee payment: 14 Ref country code: SI Payment date: 20230421 Year of fee payment: 14 Ref country code: PL Payment date: 20230508 Year of fee payment: 14 Ref country code: LV Payment date: 20230522 Year of fee payment: 14 Ref country code: HU Payment date: 20230428 Year of fee payment: 14 Ref country code: FI Payment date: 20230526 Year of fee payment: 14 Ref country code: AL Payment date: 20230315 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20230525 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MT Payment date: 20230524 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MK Payment date: 20230426 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: HR Ref legal event code: ODRP Ref document number: P20170764 Country of ref document: HR Payment date: 20240509 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20240527 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240527 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IS Payment date: 20240524 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20240509 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240417 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LT Payment date: 20240510 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240529 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MC Payment date: 20240522 Year of fee payment: 15 Ref country code: DK Payment date: 20240527 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20240520 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240602 Year of fee payment: 15 Ref country code: HR Payment date: 20240509 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240603 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CZ Payment date: 20240509 Year of fee payment: 15 Ref country code: AT Payment date: 20240521 Year of fee payment: 15 |